# Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions

> **NCT07670234** · — · RECRUITING · sponsor: **Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI)** · enrollment: 1000 (estimated)

## Conditions studied

- Cancer (Solid Tumors)
- Interaction Drug Food

## Interventions

- **BEHAVIORAL:** Dietary Supplement Use Assessment

## Key facts

- **NCT ID:** NCT07670234
- **Lead sponsor:** Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI)
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-06
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07670234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07670234, "Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07670234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*